Eli Lilly and Company

$904.97 -0.13%
NYSE: LLY
Market Cap.: 860.1 B XL
P/E: 110.90 x34.30
EPS: 8.16 x 0.44
Earnings Call
1 month, 1 week from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 0.17%
Payout: 52.13%
Volume Level
μ 3,199,398
1,435,953 Moderate Low
Performance Ranks (Intraday)
United States:

1210th

out of

2160

Healthcare:

484th

out of

792

Drug Manufacturers—General:

35th

out of

62

Peer Group:

4th

out of

7

About

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, …